IL44791A - Cephalosporin cleavage process - Google Patents
Cephalosporin cleavage processInfo
- Publication number
- IL44791A IL44791A IL44791A IL4479174A IL44791A IL 44791 A IL44791 A IL 44791A IL 44791 A IL44791 A IL 44791A IL 4479174 A IL4479174 A IL 4479174A IL 44791 A IL44791 A IL 44791A
- Authority
- IL
- Israel
- Prior art keywords
- acid
- cephalosporin
- hydrazine
- treatment
- reacted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (12)
1. A process for cleaving the amic acid function ΐ:ι of a 7- (amic acid) cephalosporin having the formula 0 COO R I in which R and R are hydrogen, or R and R taken together a a with the carbon atoms to which they are attached represent an ortho-phenylene ring; R^ is a carboxy protecting group; and 2 is hydrogen, acetoxy, methoxy, methylthio, (5-methyl-l , 3 , 4- thiadiazol-2-yl ) thio , or ( l-methyl-lH-tetrazol-5-yl ) thio ; which comprises (1) reacting said 7- (amic acid) cephalosporin with an alkyl chloroformate in the presence of a tertiary amine to form the corresponding mixed anhydride having the formula 0 in which R, is an alkyl group having from 1 to 4 carbon atoms; X- 3996 - 35 - (2) reacting the product mixture from the aforementioned chlorofprmate treatment with a hydrazine of the formula R3HNNHR4 in which ^ and R^ independently are hydrogen or methyl; and (3) a) reacting the reaction mixture from the aforementioned hydrazine treatment with an acyl halide to produce the corresponding 7-acylamido cephalosporin; or b) when at least one of R3 and ^ is methyl, recovering the corresponding 7-amino cephalosporin from the reaction 10 mixture of the aforementioned hydrazine treatment; or c) when R^ and R^ are hydrogen, heating the reaction mixture from the aforementioned hydrazine treatment to a temperature of from about 50 °C. to about 100 °C. to produce the corresponding 7-amino cephalosporin; or d) when R^ and R^ are hydrogen, reacting the reaction mixture from the aforementioned hydrazine treatment with acid to produce the corresponding 7-amino cephalosporin in the form of its acid addition salt.
2. Process of claim 1, in which the reaction 20 mixture from the hydrazine treatment is reacted with an acyl halide to produce the corresponding 7-acylamido cephalosporin.
3. Process of claim 1, in which the product mixture from the chloroformate treatment is reacted with a hydrazine in which at least one of R^ and R^ is methyl, and the 7-amino cephalosporin is recovered from the reaction mixture.
4. Process of claim 1, in which the product mixture from the chloroformate treatment is reacted with a hydrazine in which R_ and R. are hydrogen, and the resulting X-3996 -36- reaction mixture is heated to a temperature of from about 50°C. to about 100°C. to produce the 7-amino cephalosporin.
5. Process of claim 1, in which the product mixture from the chloroformate treatment is reacted with a hydrazine in which R3 and R4 are hydrogen, and the :■-,,->- resulting reaction mixture is reacted with acid to produce the 7-amino cephalosporin in the form of its acid addition sal .
6. Process of any of claims 1 to 5, in which the . 10 amic acid cephalosporin is reacted with an alkyl chloroformate in the presence of a tertiary amine at a temperature of from about -20°C. to about +5°C.
7. Process of any of claims .1 to 6, in which the alkyl chloroformate is ethyl chloroformate .
8. Process of claim 5, in which the product mixture from the chloroformate treatment is first reacted with up to 1 equivalent of a hydrazine in which and are hydrogen per equivalent of the amic acid at a temperature of from about -10 °C. to about room temperature for from about 1 to about 20 10 minutes, and the resulting reaction mixture is reacted with from about 1 to about 2 equivalents of an acid selected from the group consisting of hydrochloric acid, hydrobromic acid, phosphoric acid, p-toluenesulfonic acid, methanesulfonic acid, and sulfuric acid per equivalent of the original amic ... acid for about 5 to about 10 minutes to produce the corresponding 7-amino cephalosporin in the form of its acid addition salt.. X-3996 -37-
9. Process of claim 3, in which the product mixture from the chloroformate treatment is first reacted with up to 1 equivalent of a hydrazine in which at least one of and R4 is methyl per equivalent of the amic acid at a temperature of from about -10 °C. to about room temperature for from about 1 to about 10 minutes to produce the corresponding 7-amino cephalosporin.
10. Process of any of claims 1 to 9 for cleaving the amic acid function of a compound of formula I in which R and R are hydrogen. el
11. Process of any of claims 1 to 9 for cleaving the amic acid function of a compound of formula I in which R and R¾ taken together with the carbon atoms to which they are attached represent an ortho-phenylene ring.
12. A process for cleaving the amic acid function of a 7- (amic acid) cephalosporin substantially as hereinbefore described with particular reference to the examples. S. HOROWITZ & CO. AGENTS FOR APPLICANTS X-3996 -38-
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US371011A US3905966A (en) | 1973-06-18 | 1973-06-18 | Cephalosporin cleavage process |
Publications (2)
Publication Number | Publication Date |
---|---|
IL44791A0 IL44791A0 (en) | 1974-07-31 |
IL44791A true IL44791A (en) | 1976-09-30 |
Family
ID=23462129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL44791A IL44791A (en) | 1973-06-18 | 1974-05-09 | Cephalosporin cleavage process |
Country Status (12)
Country | Link |
---|---|
US (1) | US3905966A (en) |
JP (1) | JPS61352B2 (en) |
BE (1) | BE816408A (en) |
CA (1) | CA1018155A (en) |
CH (1) | CH601313A5 (en) |
DE (1) | DE2429166A1 (en) |
ES (2) | ES427388A1 (en) |
FR (1) | FR2233328B1 (en) |
GB (1) | GB1474544A (en) |
IE (1) | IE39253B1 (en) |
IL (1) | IL44791A (en) |
NL (1) | NL7408170A (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001239A (en) * | 1973-06-18 | 1977-01-04 | Eli Lilly And Company | Cephalosporin cleavage process |
US3994888A (en) * | 1973-06-18 | 1976-11-30 | Eli Lilly And Company | Cephalosporin cleavage process |
US4039535A (en) * | 1973-12-10 | 1977-08-02 | Eli Lilly And Company | 7-[α-(GUANYL-1-UREIDO)PHENYLACETAMIDO]-3-SUBSTITUTED CEPHALOSPORIN ANTIBIOTICS |
JPS52124221A (en) * | 1976-04-10 | 1977-10-19 | Toshizou Miyai | Water tpa with selffclosing valve |
US5239069A (en) * | 1990-05-14 | 1993-08-24 | Eli Lilly And Company | Amino protecting group |
US5169945A (en) * | 1990-05-14 | 1992-12-08 | Eli Lilly And Company | Amino protecting group |
CA2041897A1 (en) * | 1990-05-14 | 1991-11-15 | Leland Otto Weigel | Amino protecting group |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3487074A (en) * | 1966-01-14 | 1969-12-30 | Bristol Myers Co | Derivatives of 6-amino-3-penamylcarboxylic acid and 7-amino-2,2-dimethyl-cephalosporanic acid |
US3487070A (en) * | 1966-01-14 | 1969-12-30 | Bristol Myers Co | 3-blocked amino-4-sulfhydryl-2-azetidinones |
US3769281A (en) * | 1970-07-09 | 1973-10-30 | Lilly Co Eli | Deblocking process for cephalosporin antibiotics |
-
1973
- 1973-06-18 US US371011A patent/US3905966A/en not_active Expired - Lifetime
-
1974
- 1974-05-07 IE IE963/74A patent/IE39253B1/en unknown
- 1974-05-09 IL IL44791A patent/IL44791A/en unknown
- 1974-05-15 CA CA199,956A patent/CA1018155A/en not_active Expired
- 1974-06-12 GB GB2683874A patent/GB1474544A/en not_active Expired
- 1974-06-17 BE BE1006024A patent/BE816408A/en unknown
- 1974-06-18 CH CH831974A patent/CH601313A5/xx not_active IP Right Cessation
- 1974-06-18 NL NL7408170A patent/NL7408170A/xx not_active Application Discontinuation
- 1974-06-18 JP JP49070086A patent/JPS61352B2/ja not_active Expired
- 1974-06-18 DE DE2429166A patent/DE2429166A1/en not_active Withdrawn
- 1974-06-18 FR FR7421140A patent/FR2233328B1/fr not_active Expired
- 1974-06-18 ES ES427388A patent/ES427388A1/en not_active Expired
-
1976
- 1976-05-17 ES ES448016A patent/ES448016A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB1474544A (en) | 1977-05-25 |
US3905966A (en) | 1975-09-16 |
IE39253B1 (en) | 1978-08-30 |
IL44791A0 (en) | 1974-07-31 |
FR2233328A1 (en) | 1975-01-10 |
ES448016A1 (en) | 1977-07-01 |
NL7408170A (en) | 1974-12-20 |
CH601313A5 (en) | 1978-07-14 |
JPS61352B2 (en) | 1986-01-08 |
FR2233328B1 (en) | 1977-10-07 |
CA1018155A (en) | 1977-09-27 |
DE2429166A1 (en) | 1975-01-09 |
BE816408A (en) | 1974-12-17 |
ES427388A1 (en) | 1976-09-16 |
JPS5036488A (en) | 1975-04-05 |
IE39253L (en) | 1974-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL44791A (en) | Cephalosporin cleavage process | |
ES412859A1 (en) | Process for preparing 7-(alpha-hydroxy-alpha-phenyl)acetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid and derivatives thereof | |
GB1009302A (en) | Organic peroxides and a process for preparing them | |
ATE19631T1 (en) | PROCESS FOR THE PREPARATION OF (3S)-3-(((2-AMINO-4-THIAZOLYL)-((1-CARBOXY-1-ME HYLETHOXY)-IMINO)ACETYL)-AMINO)-2-OXO-1-AZETIDINE SULPHONE| URE AND 4- SUBSTITUTED DERIVATIVES. | |
HUT36799A (en) | Process for producing cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them | |
DE3069173D1 (en) | Substituted phenylamino-2-imidazoline-2 derivatives, their acid addition salts, medicaments containing them and process for their preparation | |
EP0187209A3 (en) | Process for the preparation of cephalosporins | |
KR910009713A (en) | 3-fluorosulfonyloxysef-3-m substitution method | |
SE7600585L (en) | PROCEDURE FOR THE PREPARATION OF 7-AMINOCEFALOSPORANIC ACID DERIVATIVES | |
GB1474545A (en) | Penicillin and cephalosporin cleavage process and compounds useful therein | |
AU723133B2 (en) | Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof | |
KR900018011A (en) | Process for preparing acyl cyanide in anhydrous medium | |
US3763152A (en) | Neutral cephalosporin anhydrides | |
DE69225651T2 (en) | USE OF HALOGENATED BETA LACTAMES FOR THE PRODUCTION OF 3-HYDROXYCEPHEM DERIVATIVES | |
KR100498894B1 (en) | Process for producing 1-chlorocarbonyl-4-piperidino- piperidine or hydrochloride thereof | |
SE7503560L (en) | ||
GR3021336T3 (en) | New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof. | |
JPS5653684A (en) | Production of cephalosporin derivative | |
JPS55151547A (en) | Production of guanidinocapronic ester | |
JPS54112891A (en) | Preparation of 7-substituted aminocephalosporanic acid derivative | |
ES8106281A1 (en) | Preparation of aminosulphonic acids and their derivatives. | |
GB1043502A (en) | New betaines and process for their manufacture | |
GB1482388A (en) | Method of producing 6-beta-amidinopenicillanic acid derivatives | |
JPS5331628A (en) | Isolation and purification of aromatic compounds with monohalogenated side chains | |
JPS56158790A (en) | Preparation of cephalosporin derivative |